|Bid||0.7002 x 2900|
|Ask||0.9000 x 900|
|Day's Range||0.7301 - 0.8100|
|52 Week Range||0.6500 - 4.7500|
|Beta (3Y Monthly)||1.25|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Nearly two years after halting multiple clinical trials due to the deaths of three participants for what's described as unrelated reasons, Kendall Square medical device maker InVivo Therapeutics Corp. has launched its first new trial of an implant it believes could help heal spinal cord injuries.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 42 cents. In the final minutes of trading on Thursday, the company's shares hit $2.09. A year ago, they were trading ...
The Cambridge, Massachusetts-based company said it had a loss of $7.48 per share. In the final minutes of trading on Tuesday, the company's shares hit $2.08. A year ago, they were trading at $50. _____ ...